Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 27

Related Articles by Review for PubMed (Select 11333991)

1.
2.

The impact of race on response to RAAS inhibition.

Wallace TW, Drazner MH.

Curr Heart Fail Rep. 2005 Aug;2(2):72-7. Review.

PMID:
16036054
3.
4.

ACE inhibitors in heart failure: what more do we need to know?

Demers C, Mody A, Teo KK, McKelvie RS.

Am J Cardiovasc Drugs. 2005;5(6):351-9. Review.

PMID:
16259523
5.

Congestive heart failure: new therapeutic strategies.

Pitt B.

Clin Cardiol. 1992 Sep;15 Suppl 1:I2-4. Review.

PMID:
1395211
6.

Racial differences in responses to drug treatment: implications for pharmacotherapy of heart failure.

Taylor JS, Ellis GR.

Am J Cardiovasc Drugs. 2002;2(6):389-99. Review.

PMID:
14727954
8.

Role of converting enzyme inhibitors in the treatment of heart failure.

Hood WB Jr.

J Am Coll Cardiol. 1993 Oct;22(4 Suppl A):154A-157A. Review.

PMID:
8376687
9.

Lessons from recent randomized controlled trials for the management of congestive heart failure.

Riegger GA.

Am J Cardiol. 1993 Jun 24;71(17):38E-40E. Review.

PMID:
8328366
10.
11.

Racial response to angiotensin-converting enzyme therapy in systolic heart failure.

Dries DJ, Yancy CW, Strong MA, Drazner MH.

Congest Heart Fail. 2004 Jan-Feb;10(1):30-3. Review.

PMID:
14872155
12.

[Does any evidence exist to treat heart failure based on race or ethnicity?].

Latado AL, Lopes MB, Passos LC, Lopes AA.

Rev Assoc Med Bras. 2009 Mar-Apr;55(2):110-6. Review. Portuguese.

13.

[Congestive heart failure and acute myocardial infarction: latest trials with beta-blocking agents].

Isnard R.

Ann Cardiol Angeiol (Paris). 2002 Jan;51(1):48-50. Review. French. No abstract available.

PMID:
12510669
14.

Effects of long-term treatment with angiotensin-converting-enzyme inhibitors in the presence or absence of aspirin: a systematic review.

Teo KK, Yusuf S, Pfeffer M, Torp-Pedersen C, Kober L, Hall A, Pogue J, Latini R, Collins R; ACE Inhibitors Collaborative Group.

Lancet. 2002 Oct 5;360(9339):1037-43. Review. Erratum in: Lancet 2003 Jan 4;361(9351):90.

PMID:
12383982
15.
16.

Effect of B-type natriuretic peptide-guided treatment of chronic heart failure on total mortality and hospitalization: an individual patient meta-analysis.

Troughton RW, Frampton CM, Brunner-La Rocca HP, Pfisterer M, Eurlings LW, Erntell H, Persson H, O'Connor CM, Moertl D, Karlström P, Dahlström U, Gaggin HK, Januzzi JL, Berger R, Richards AM, Pinto YM, Nicholls MG.

Eur Heart J. 2014 Jun 14;35(23):1559-67. doi: 10.1093/eurheartj/ehu090. Epub 2014 Mar 6. Review.

17.

Role of cardioprotective therapy for prevention of cardiotoxicity with chemotherapy: a systematic review and meta-analysis.

Kalam K, Marwick TH.

Eur J Cancer. 2013 Sep;49(13):2900-9. doi: 10.1016/j.ejca.2013.04.030. Epub 2013 May 22. Review.

PMID:
23706982
18.

Heart rate and heart failure. Not a simple relationship.

Heusch G.

Circ J. 2011;75(2):229-36. Epub 2010 Oct 28. Review.

19.

[X-SOLVD].

Kubota T.

Nihon Rinsho. 2007 Apr 28;65 Suppl 4:516-20. Review. Japanese. No abstract available.

PMID:
17511102
20.

Selection of endpoints for heart failure clinical trials.

Zanolla L, Zardini P.

Eur J Heart Fail. 2003 Dec;5(6):717-23. Review.

PMID:
14675849
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk